• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清素缺乏的新生小鼠不能预防实验性支气管肺发育不良或肺动脉高压的发生。

Serotonin-deficient neonatal mice are not protected against the development of experimental bronchopulmonary dysplasia or pulmonary hypertension.

机构信息

Section of Neonatology, Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.

Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.

出版信息

Physiol Rep. 2022 Oct;10(19):e15482. doi: 10.14814/phy2.15482.

DOI:10.14814/phy2.15482
PMID:36200294
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9535350/
Abstract

Serotonin (5-hydroxytryptamine, 5-HT) is a potent pulmonary vasoconstrictor and contributes to high pulmonary vascular resistance in the developing ovine lung. In experimental pulmonary hypertension (PH), pulmonary expression of tryptophan hydroxylase-1 (TPH1), the rate limiting enzyme in 5-HT synthesis, and plasma 5-HT are increased. 5-HT blockade increases pulmonary blood flow and prevents pulmonary vascular remodeling and PH in neonatal models of PH with bronchopulmonary dysplasia (BPD). We hypothesized that neonatal tph1 knock-out (KO) mice would be protected from hypoxia-induced alveolar simplification, decreased vessel density, and PH. Newborn wild-type (WT) and tph1 KO mice were exposed to normoxia or hypoxia for 2 weeks. Normoxic WT and KO mice exhibited similar alveolar development, pulmonary vascular density, right ventricular systolic pressures (RVSPs), and right heart size. Circulating (plasma and platelet) 5-HT decreased in both hypoxia-exposed WT and KO mice. Tph1 KO mice were not protected from hypoxia-induced alveolar simplification, decreased pulmonary vascular density, or right ventricular hypertrophy, but displayed attenuation to hypoxia-induced RVSP elevation compared with WT mice. Tph1 KO neonatal mice are not protected against hypoxia-induced alveolar simplification, reduction in pulmonary vessel density, or RVH. While genetic and pharmacologic inhibition of tph1 has protective effects in adult models of PH, our results suggest that tph1 inhibition would not be beneficial in neonates with PH associated with BPD.

摘要

5-羟色胺(5-HT)是一种有效的肺血管收缩剂,在发育中的羊肺中导致高肺血管阻力。在实验性肺动脉高压(PH)中,5-HT 合成的限速酶色氨酸羟化酶-1(TPH1)的肺表达和血浆 5-HT 增加。5-HT 阻断可增加肺血流量,并预防伴有支气管肺发育不良(BPD)的新生儿 PH 模型中的肺血管重塑和 PH。我们假设,新生 tph1 敲除(KO)小鼠将免受缺氧引起的肺泡简化、血管密度降低和 PH 的影响。新生野生型(WT)和 tph1 KO 小鼠分别暴露于常氧或缺氧 2 周。常氧 WT 和 KO 小鼠表现出相似的肺泡发育、肺血管密度、右心室收缩压(RVSP)和右心大小。在缺氧暴露的 WT 和 KO 小鼠中,循环(血浆和血小板)5-HT 均降低。与 WT 小鼠相比,tph1 KO 小鼠并未免受缺氧引起的肺泡简化、肺血管密度降低或右心室肥大的影响,但对缺氧引起的 RVSP 升高的反应减弱。tph1 KO 新生小鼠不能防止与 BPD 相关的 PH 引起的肺泡简化、肺血管密度降低或 RVH。虽然 tph1 的遗传和药理学抑制在成人 PH 模型中具有保护作用,但我们的结果表明,tph1 抑制在伴有 BPD 的 PH 的新生儿中可能没有益处。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e23d/9535350/86f81e615f3c/PHY2-10-e15482-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e23d/9535350/9851ee6384ba/PHY2-10-e15482-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e23d/9535350/6c5a4c8e9cdb/PHY2-10-e15482-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e23d/9535350/f168e98fff32/PHY2-10-e15482-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e23d/9535350/e060d39418f8/PHY2-10-e15482-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e23d/9535350/726ec3baf8c9/PHY2-10-e15482-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e23d/9535350/86f81e615f3c/PHY2-10-e15482-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e23d/9535350/9851ee6384ba/PHY2-10-e15482-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e23d/9535350/6c5a4c8e9cdb/PHY2-10-e15482-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e23d/9535350/f168e98fff32/PHY2-10-e15482-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e23d/9535350/e060d39418f8/PHY2-10-e15482-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e23d/9535350/726ec3baf8c9/PHY2-10-e15482-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e23d/9535350/86f81e615f3c/PHY2-10-e15482-g005.jpg

相似文献

1
Serotonin-deficient neonatal mice are not protected against the development of experimental bronchopulmonary dysplasia or pulmonary hypertension.血清素缺乏的新生小鼠不能预防实验性支气管肺发育不良或肺动脉高压的发生。
Physiol Rep. 2022 Oct;10(19):e15482. doi: 10.14814/phy2.15482.
2
Serotonin 2A receptor inhibition protects against the development of pulmonary hypertension and pulmonary vascular remodeling in neonatal mice.5-羟色胺 2A 受体抑制可预防新生小鼠肺动脉高压和肺血管重构。
Am J Physiol Lung Cell Mol Physiol. 2018 May 1;314(5):L871-L881. doi: 10.1152/ajplung.00215.2017. Epub 2018 Jan 18.
3
Lack of EC-SOD worsens alveolar and vascular development in a neonatal mouse model of bleomycin-induced bronchopulmonary dysplasia and pulmonary hypertension.在博来霉素诱导的支气管肺发育不良和肺动脉高压新生小鼠模型中,细胞外超氧化物歧化酶(EC-SOD)的缺乏会使肺泡和血管发育恶化。
Pediatr Res. 2015 Dec;78(6):634-40. doi: 10.1038/pr.2015.166. Epub 2015 Aug 31.
4
Tryptophan hydroxylase 1 knockout and tryptophan hydroxylase 2 polymorphism: effects on hypoxic pulmonary hypertension in mice.色氨酸羟化酶1基因敲除与色氨酸羟化酶2基因多态性:对小鼠低氧性肺动脉高压的影响
Am J Physiol Lung Cell Mol Physiol. 2007 Oct;293(4):L1045-52. doi: 10.1152/ajplung.00082.2007. Epub 2007 Aug 3.
5
Imatinib attenuates hypoxia-induced pulmonary arterial hypertension pathology via reduction in 5-hydroxytryptamine through inhibition of tryptophan hydroxylase 1 expression.伊马替尼通过抑制色氨酸羟化酶 1 的表达减少 5-羟色胺从而减轻低氧诱导的肺动脉高压病理。
Am J Respir Crit Care Med. 2013 Jan 1;187(1):78-89. doi: 10.1164/rccm.201206-1028OC. Epub 2012 Oct 18.
6
Inhibition of gut- and lung-derived serotonin attenuates pulmonary hypertension in mice.抑制肠道和肺部来源的 5-羟色胺可减轻小鼠的肺动脉高压。
Am J Physiol Lung Cell Mol Physiol. 2012 Sep 15;303(6):L500-8. doi: 10.1152/ajplung.00049.2012. Epub 2012 Jul 13.
7
Effect of tryptophan hydroxylase 1 deficiency on the development of hypoxia-induced pulmonary hypertension.色氨酸羟化酶1缺乏对缺氧诱导的肺动脉高压发展的影响。
Hypertension. 2007 Jan;49(1):232-6. doi: 10.1161/01.HYP.0000252210.58849.78. Epub 2006 Nov 27.
8
Genetic ablation of interleukin-18 does not attenuate hypobaric hypoxia-induced right ventricular hypertrophy.基因敲除白细胞介素-18 不能减轻低压低氧诱导的右心室肥厚。
Am J Physiol Lung Cell Mol Physiol. 2016 Mar 15;310(6):L542-50. doi: 10.1152/ajplung.00166.2015. Epub 2016 Jan 8.
9
The nuclear factor erythroid 2-related factor 2 activator oltipraz attenuates chronic hypoxia-induced cardiopulmonary alterations in mice.核因子红细胞 2 相关因子 2 激活剂奥替普拉减轻小鼠慢性缺氧引起的心肺改变。
Am J Respir Cell Mol Biol. 2013 Aug;49(2):324-33. doi: 10.1165/rcmb.2011-0396OC.
10
Vascular smooth muscle ROCK1 contributes to hypoxia-induced pulmonary hypertension development in mice.血管平滑肌 ROCK1 促进小鼠低氧性肺动脉高压的发展。
Biochem Biophys Res Commun. 2022 May 14;604:137-143. doi: 10.1016/j.bbrc.2022.02.064. Epub 2022 Mar 9.

引用本文的文献

1
A maternal hypoxia mouse model to study the effect of late gestational hypoxia on offspring lung outcomes.一种用于研究妊娠晚期缺氧对后代肺部结局影响的母体缺氧小鼠模型。
Front Physiol. 2025 Feb 27;16:1513703. doi: 10.3389/fphys.2025.1513703. eCollection 2025.
2
A Review of Serotonin in the Developing Lung and Neonatal Pulmonary Hypertension.发育中的肺脏与新生儿肺动脉高压中的血清素综述
Biomedicines. 2023 Nov 14;11(11):3049. doi: 10.3390/biomedicines11113049.

本文引用的文献

1
Platelet activation in experimental murine neonatal pulmonary hypertension.实验性新生鼠肺动脉高压中血小板的激活。
Physiol Rep. 2020 Mar;8(5):e14386. doi: 10.14814/phy2.14386.
2
MicroRNA dysregulation in lung injury: the role of the miR-26a/EphA2 axis in regulation of endothelial permeability.miRNA 失调与肺损伤:miR-26a/EphA2 轴在调节血管内皮通透性中的作用。
Am J Physiol Lung Cell Mol Physiol. 2018 Oct 1;315(4):L584-L594. doi: 10.1152/ajplung.00073.2017. Epub 2018 Jul 19.
3
The serotonin hypothesis in pulmonary hypertension revisited: targets for novel therapies (2017 Grover Conference Series).
肺动脉高压中的血清素假说再探讨:新型疗法的靶点(2017年格罗弗会议系列)
Pulm Circ. 2018 Apr-Jun;8(2):2045894018759125. doi: 10.1177/2045894018759125.
4
Serotonin 2A receptor inhibition protects against the development of pulmonary hypertension and pulmonary vascular remodeling in neonatal mice.5-羟色胺 2A 受体抑制可预防新生小鼠肺动脉高压和肺血管重构。
Am J Physiol Lung Cell Mol Physiol. 2018 May 1;314(5):L871-L881. doi: 10.1152/ajplung.00215.2017. Epub 2018 Jan 18.
5
The Role of Serotonin Transporter in Human Lung Development and in Neonatal Lung Disorders.血清素转运体在人类肺发育及新生儿肺部疾病中的作用
Can Respir J. 2017;2017:9064046. doi: 10.1155/2017/9064046. Epub 2017 Feb 20.
6
Tryptophan hydroxylase 1 Inhibition Impacts Pulmonary Vascular Remodeling in Two Rat Models of Pulmonary Hypertension.色氨酸羟化酶1抑制对两种肺动脉高压大鼠模型肺血管重塑的影响
J Pharmacol Exp Ther. 2017 Feb;360(2):267-279. doi: 10.1124/jpet.116.237933. Epub 2016 Dec 7.
7
Trends in Care Practices, Morbidity, and Mortality of Extremely Preterm Neonates, 1993-2012.1993 - 2012年极早产儿的护理实践、发病率及死亡率趋势
JAMA. 2015 Sep 8;314(10):1039-51. doi: 10.1001/jama.2015.10244.
8
Early pulmonary vascular disease in preterm infants at risk for bronchopulmonary dysplasia.有患支气管肺发育不良风险的早产儿的早期肺血管疾病
Am J Respir Crit Care Med. 2015 Jan 1;191(1):87-95. doi: 10.1164/rccm.201409-1594OC.
9
Serotonin drives the activation of pulmonary artery adventitial fibroblasts and TGF-β1/Smad3-mediated fibrotic responses through 5-HT(2A) receptors.血清素通过5-HT(2A)受体驱动肺动脉外膜成纤维细胞的激活以及TGF-β1/Smad3介导的纤维化反应。
Mol Cell Biochem. 2014 Dec;397(1-2):267-76. doi: 10.1007/s11010-014-2194-0. Epub 2014 Sep 4.
10
Venous plasma serotonin is not a proper biomarker for pulmonary arterial hypertension.静脉血浆血清素并非肺动脉高压的合适生物标志物。
Scand Cardiovasc J. 2014 Apr;48(2):106-10. doi: 10.3109/14017431.2014.886335. Epub 2014 Feb 24.